Indian drugmakers seek exemption for generics from US supplies probe

Indian pharmaceutical industry representatives met with Union Commerce Minister Piyush Goyal. They requested the US government to exclude generic drugs from its investigation into pharmaceutical imports. The probe, under Section 232, raises concerns about supply chain disruptions. This discussion occurs amidst India-US trade negotiations and potential US tariffs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/J3tBKf9
via IFTTT